Awm Investment Company, Inc. Akari Therapeutics PLC Transaction History

Awm Investment Company, Inc.

  • $732 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 10, 2018
SELL
$1.77 - $4.39 $1.21 Million - $3 Million
-684,000 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$4.08 - $7.4 $2.79 Million - $5.06 Million
684,000
684,000 $2.96 Million

About Akari Therapeutics Plc

AKTX Quotes by TradingView
  • Ticker AKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,349,200
  • Market Cap $59.3M
  • Description
  • Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...
More about AKTX
Track This Portfolio

Track Awm Investment Company, Inc. Portfolio

Follow Awm Investment Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Awm Investment Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email